Document ID: EPA-HQ-OPP-2005-0043-0117
Agency: epa
Document Type: Supporting & Related Material
Title: 
Posted Date: 2012-08-17T04:00Z

Appendix C: Technical Support Documents

	Additional documentation in support of this RED is maintained in the
OPP docket, located in room S-4400, One Potomac Yard (South Building),
2777 S. Crystal Drive, Arlington, VA 22202. It is open Monday through
Friday, excluding legal holidays, from 8:30 am to 4 pm.

	All documents, in hard copy form, may be viewed in the OPP docket room
or downloaded or viewed via the Internet at the following site: http:// 
  HYPERLINK "http://www.epa.gov/REDs/"  www.regulations.gov 		

These documents include:

HED Documents:

Pyrethrins: Human Health Aggregate Risk Assessment to Account for Pet
Spray Ues Rate Correction.  T. Dole; D347781; January 24, 2008.  

Pyrethrins:  Occupational and Residential Exposure Assessment to Account
for Pet Spray Use Rate Correction.  T. Dole; D347780; January 4, 2008.

Pyrethrins:  Revised Human Health Risk Assessment for the Reregistration
Eligibility Decision.  Olinger, C.; D326648; March 16, 2006.

Pyrethrins:  Responses to Public Comments on HED Risk Assessment and
Supporting Documents; Olinger, C., et al.; D 324662; January 31, 2006. 

  SEQ CHAPTER \h \r 1 Review of Pyrethrins Incident Reports - Second
Revision.  Blondell, J.; D320300;   SEQ CHAPTER \h \r 1 August 16, 2005.

Three Pyrethrin Health Effects Reviews: Mosby and Registrant
Submissions.  Allen, Ruth; D326085; July 2006.

  SEQ CHAPTER \h \r 1 Pyrethrins. Revised Residue Chemistry
Considerations for Reregistration Eligibility Decision.  Deluzio, J. and
Olinger, C.; D   SEQ CHAPTER \h \r 1 318633;   SEQ CHAPTER \h \r 1
September 8, 2005.

  SEQ CHAPTER \h \r 1 Pyrethrins RED - Reregistration Eligibility
Decision.  Product Chemistry Considerations.    SEQ CHAPTER \h \r 1
Deluzio, Joseph; D  SEQ CHAPTER \h \r 1 309022; March 21, 2005.

  SEQ CHAPTER \h \r 1 Pyrethrins: Report of the Cancer Assessment Review
Committee (Third Evaluation).    SEQ CHAPTER \h \r 1 Kidwell, Jessica;  
SEQ CHAPTER \h \r 1 TXR No.0052631,   SEQ CHAPTER \h \r 1 June 22, 2004.

  SEQ CHAPTER \h \r 1 Pyrethrins.  Acute and Chronic Dietary Exposure
Assessment for the Reassessment Eligibility Decision (RED) Document. 
Deluzio, Joseph;   SEQ CHAPTER \h \r 1 D295748;   SEQ CHAPTER \h \r 1
December 20, 2004.

  SEQ CHAPTER \h \r 1 PYRETHRINS Reregistration Branch 1/Health Effects
Division Response to Comments on Draft Risk Assessment.  Taylor, Linda;
D320383;   SEQ CHAPTER \h \r 1 TXR# 0053661,   SEQ CHAPTER \h \r 1
August 17, 2005.

Pyrethrins: 2nd Revised Occupational and Residential Exposure Assessment
and Recommendations for the Reregistration Eligibility Decision (RED). 
Dole, T. and Lloyd, M.; D318630; September 7, 2005.	

Occupational and Residential Exposure Assessment for the Use of
Pyrethrin in Residential Mosquito Mister Systems. Dole, Timothy;
D315335; September 7, 2005.  

Piperonyl Butoxide (PBO), Pyrethrins and MGK-264:  Health Effects
Division’s response to the Registrant’s concerns for using
metaplasia seen in the larynx in subchronic inhalation studies as an
endpoint for inhalation risk assessment.  Ramasamy, S., et al.; D319913,
D319914, and D320298; September 8, 2005.

Pyrethrins: Occupational Exposure Assessment for Indoor Fogging
Applications.  Dole, T.; D330441; July 5, 2006.

Revised Occupational and Residential Exposure Assessment for the Use of
Pyrethrins in Residential Mosquito Mister Systems.  Dole, T.; D330442;
July 5, 2006.

	

EFED Documents:

  SEQ CHAPTER \h \r 1 Revised Pyrethrins RED Chapter After Additional
60-Day Comment Period, Phase 5.  Rexrode, M. and Meléndez, J.; D324663;
  SEQ CHAPTER \h \r 1 January 25, 2006.  

Response to Comments of Phase 5 Period About Water Quality, and Other
Issues on the Revised Draft EFED RED Chapters for Pyrethrins, PBO and
MGK-264.  Davy, M., et al.; D324663, D324664, D324667, D324662, D324671,
and D324673; January 30, 2006. 

  SEQ CHAPTER \h \r 1 Tier 1 Estimated Drinking Water Concentrations of
Pyrethrin and Derivatives for use in Human Health Risk Assessment.   
SEQ CHAPTER \h \r 1 Dutta, Subijoy;   SEQ CHAPTER \h \r 1 D295750;   SEQ
CHAPTER \h \r 1 August 19, 2004.